No article text was recorded for this version.
disease-specific metabolic signatures
Version 1 of 123 papers26 conceptsfrozen 2026-10-04
Papers in this version
- Blog: Characteristics of Blood Metabolic Profile in Coronary Heart Disease, Dilated Cardiomyopathy and Valvular Heart Disease Induced Heart Failure
- Blog: Plasma Metabolomic Profiles Differentiate Patients With Dilated Cardiomyopathy and Ischemic Cardiomyopathy
- Blog: Gut microbiota composition and metabolic characteristics in patients with Craniopharyngioma
- Blog: Bariatric Surgery Improves the Atherogenic Profile of Circulating Methylarginines in Obese Patients: Results from a Pilot Study
- Blog: Saliva microbiome alterations in dental fluorosis population
- Blog: The impact of Helicobacter pylori infection and eradication therapy containing minocycline and metronidazole on intestinal microbiota
- Blog: Oral Microbiome in Nonsmoker Patients with Oral Cavity Squamous Cell Carcinoma, Defined by Metagenomic Shotgun Sequencing
- Blog: Metagenome-wide association of gut microbiome features for schizophrenia
- Blog: Untargeted metabolomics for uncovering plasma biological markers of wet age-related macular degeneration
- Blog: 7th Santorini Conference “Biologie Prospective”Systems Medicine, Personalized Health and Therapy in collaboration with ESPT
- Blog: Metabolic Signatures of Kidney<i>Yang</i>Deficiency Syndrome and Protective Effects of Two Herbal Extracts in Rats Using GC/TOF MS
- Blog: Metabolomes of mitochondrial diseases and inclusion body myositis patients: treatment targets and biomarkers
- Blog: Dysbiosis of the Salivary Microbiome Is Associated With Non-smoking Female Lung Cancer and Correlated With Immunocytochemistry Markers
- Blog: Frequent exacerbators of chronic obstructive pulmonary disease have distinguishable sputum microbiome signatures during clinical stability
- Blog: Compositional and Functional Analysis of the Microbiome in Tissue and Saliva of Oral Squamous Cell Carcinoma
- Blog: A probabilistic pathway score (PROPS) for classification with applications to inflammatory bowel disease
- Blog: Comparison of Erythrocyte Membrane Lipid Profiles between NAFLD Patients with or without Hyperlipidemia
- Blog: Interactions between Cryptosporidium, Enterocytozoon, Giardia and Intestinal Microbiota in Bactrian Camels on Qinghai-Tibet Plateau, China
- Blog: Lung microbiome in children with hematological malignancies and lower respiratory tract infections
- Blog: New potential biomarkers of ulcerative colitis and disease course — integrated metagenomic and metabolomic analysis among Polish patients
- Blog: Diagnostic potential of salivary microbiota in persistent pulmonary nodules: identifying biomarkers and functional pathways using 16S rRNA sequencing and machine learning
- Blog: Comparative analysis of bile metabolic profile in patients with biliary obstruction complicated by Clonorchis sinensis infection
- Blog: Untargeted Metabolomics Reveal Parenteral Nutrition-Associated Alterations in Pediatric Patients with Short Bowel Syndrome
History & citation
Current · Permanent link
Cite this direction
Latest version (a living page):
@misc{lacuna_disease_specific_metabolic_signatures_2bfa9454,
title = {disease-specific metabolic signatures},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/disease-specific-metabolic-signatures/rdr_2bfa94547bde4931a4fe34a17663aa00},
note = {Latest version of a living research direction; cite a version for a fixed text. Accessed 2026-11-20},
}This exact version (version 1, frozen text):
@misc{lacuna_disease_specific_metabolic_signatures_2bfa9454_v1,
title = {disease-specific metabolic signatures},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/disease-specific-metabolic-signatures/rdr_2bfa94547bde4931a4fe34a17663aa00/v/1},
note = {Version 1, frozen 2026-10-04. Accessed 2026-11-20},
}